You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-Cyclooxygenase (COX)-PTUPB
PTUPB

Chemical Structure : PTUPB

CAS No.: 1287761-01-6

PTUPB

Catalog No.: PC-62501Not For Human Use, Lab Use Only.

PTUPB is a novel dual acting COX-2/sEH inhibitor with IC50 of 1.26 uM/0.9 nM, also is a potent AKR1C3 inhibitor with IC50 of 65 nM.

Packing Price Stock Quantity
10 mg $158 In stock
25 mg $258 In stock
50 mg $388 In stock
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

PTUPB is a novel dual acting COX-2/sEH inhibitor with IC50 of 1.26 uM/0.9 nM, also is a potent AKR1C3 inhibitor with IC50 of 65 nM.
PTUPBdoes not inhibits COX-1 (IC50>100 uM).
PTUPB reduces kidney injury parameters, decreases inflammatory and oxidative stress markers in ZDF rats.
PTUPB exhibits more effective than the same dose of either COX-2 inhibitor (celecoxib) or sEH inhibitor (t-AUCB) alone, shows in vivo antiallodynic activity in vivo.
PTUPB also suppresses glioblastoma growth by targeting EGFR and hyaluronan mediated motility receptor, potentiates the antitumor efficacy of cisplatin.
PTUPB inhibits CRPC proliferation by suppressing the AKR1C3/AR/AR-V7 axis and is more effective and superior to indomethacin.
PTUPB shows much better efficacy than indomethacin in castration-relapsed VCaP xenograft, patient-derived xenograft (PDX) organoid, and cell models generated from advanced prostate cancer patients.

Physicochemical Properties

M.Wt 543.565
Formula C26H24F3N5O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-(5-phenyl-3-{3-[3-(4-trifluoromethylphenyl)-ureido]-propyl}-pyrazol-1-yl)-benzenesulfonamide

References

1. Joy C Yang, et al. Oncogene. 2023 Feb;42(9):693-707.

2. Li J, et al. Oncotarget. 2017 Sep 15;8(50):87353-87363.

3. Wang F, et al. Mol Cancer Ther. 2018 Feb;17(2):474-483.

4. Hwang SH, et al. J Med Chem. 2011 Apr 28;54(8):3037-50.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: